DHR
Danaher Corporation · Healthcare · Medical - Diagnostics & Research
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 190 | +7 | 438.01M | $83.49B | +10 | −2 |
| Q1 2026 | 185 | -2 | 440.89M | $83.51B | +5 | −8 |
| Q4 2025 | 186 | -1 | 467.58M | $107.03B | +2 | −2 |
| Q3 2025 | 30 | -1 | 269.80M | $53.47B | +1 | −3 |
| Q2 2025 | 29 | +2 | 237.37M | $46.89B | +3 | −1 |
| Q1 2025 | 24 | -1 | 116.89M | $23.96B | +1 | −2 |
| Q4 2024 | 25 | +1 | 111.55M | $25.60B | +1 | — |
| Q3 2024 | 23 | +1 | 81.67M | $22.69B | +2 | −1 |
| Q2 2024 | 22 | — | 81.37M | $20.32B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 19.39M | — | $4.84B | 0.6% | n/c | 1 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 19.39M | — | $4.84B | 0.6% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passive) | 13.18M | — | $3.28B | 0.3% | n/c | 1 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passive) | 13.18M | — | $3.28B | 0.3% | n/c | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (passive) | 9.17M | — | $2.29B | 0.3% | n/c | 1 | SEC ↗ |
| 15 | Capital World Investors ✦ | 4.77M | — | $1.19B | 0.2% | n/c | 1 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 4.44M | — | $1.11B | 0.5% | n/c | 1 | SEC ↗ |
| 17 | Third Point ✦ | 2.05M | — | $512.19M | 5.9% | n/c | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 1.91M | — | $476.84M | 0.7% | n/c | 1 | SEC ↗ |
| 19 | Marshall Wace ✦ | 1.91M | — | $476.84M | 0.7% | n/c | 1 | SEC ↗ |
| 20 | Marshall Wace ✦ | 1.91M | — | $476.84M | 0.7% | n/c | 1 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 777.97K | — | $194.38M | 0.4% | n/c | 1 | SEC ↗ |
| 22 | Gates Foundation Trust ✦ | 373.00K | — | $93.19M | 0.2% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 303.43K | — | $75.81M | 0.1% | n/c | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 303.43K | — | $75.81M | 0.1% | n/c | 1 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 303.43K | — | $75.81M | 0.1% | n/c | 1 | SEC ↗ |
| 26 | Soros Fund Management ✦ | 120.00K | — | $29.98M | 0.9% | n/c | 1 | SEC ↗ |
| 27 | Millennium Management ✦ | 114.52K | — | $28.61M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Arrowstreet Capital ✦ | 88.27K | — | $22.05M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Harris Associates (Oakmark) ✦ | 72.21K | — | $18.04M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | PRIMECAP Management ✦ | 66.94K | — | $16.72M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Gotham Asset Management ✦ | 42.65K | — | $10.65M | 0.1% | n/c | 1 | SEC ↗ |
| 32 | Dodge & Cox ✦ | 16.52K | — | $4.13M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 2.70K | — | $674,595 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | D. E. Shaw & Co. ✦ | 2.70K | — | $674,595 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | GAMCO Investors ✦ | 2.24K | — | $558,665 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Bridgewater Associates ✦ | 1.80K | — | $448,731 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Citadel Advisors ✦ | 1.23K | — | $306,316 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,147 holders, 548.39M shares, $97.77B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 11.31K sh · $2.46M
Officer, Director · 39.19K sh · $8.57M
Officer, Director · 7.75K sh · $1.70M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology